Madrid, Spain

José Luis Chicharro


Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2007-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: José Luis Chicharro: Innovator in Antitumoral Compounds

Introduction

José Luis Chicharro is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumoral compounds. With a total of 2 patents, his work has garnered attention in the pharmaceutical industry.

Latest Patents

Chicharro's latest patents include a synthetic process for the manufacture of an ecteinaschidin compound. This innovative process involves preparing compounds with a fused ring structure, specifically those that include ecteinascidins with a spiroamine-1,4-bridge. The method entails forming a 1,4 bridge using a 1-labile, 10-hydroxy, 18-protected hydroxyl, di-6,8-en-5-one fused ring compound. Following the formation of the 1,4 bridge, the C-18 protection is removed before the introduction of the spiroamine. Another significant invention by Chicharro relates to antitumoral ecteinascidin derivatives, which are compounds designed to combat cancer effectively.

Career Highlights

Throughout his career, José Luis Chicharro has worked with prominent companies in the pharmaceutical sector, including Pharma Mar, S.A. and Pharmamar. His expertise in medicinal chemistry has positioned him as a valuable asset in the development of innovative therapeutic solutions.

Collaborations

Chicharro has collaborated with notable colleagues such as Andrés Francesch and Carolina Fernández. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

José Luis Chicharro's contributions to the field of medicinal chemistry, particularly in the area of antitumoral compounds, highlight his innovative spirit and dedication to improving cancer treatment. His patents reflect a commitment to advancing pharmaceutical science and enhancing therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…